Tyler Curiel, MD, MPHUniversity of Texas Health Science Center at San Antonio Improving B7-H1 blockade to treat ovarian cancer Immunotherapy theoretically should be effective for ovarian cancer but only has modest effects because of ovarian cancer-related immune dysfunction. Dr. Curiel will use a well-established pre-clinical mouse model to test rationally designed combinations of agents that […]
Read More
Steffan Nawrocki, PhDUniversity of Texas Health Science Center at San Antonio A new strategy to overcome drug resistance in ovarian cancer Platinum-based chemotherapy is prevalently used for the treatment of ovarian cancer. The prognosis for patients with platinum-resistant ovarian cancer is extremely poor, and new treatments for this disease are urgently needed. Dr. Nawrocki‘s preliminary […]
Read More